pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0TWDDC7V2Nu0xQpOBaypD_GzYaxPPPcPFlLwKHAyq&reftype=publisher&issue-id=175368&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 3(1);  February 2007
Reviews
Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
Luis Miguel Ruilope, Josep Redón, and Roland Schmieder
Vasc Health Risk Manag. 2007 February; 3(1): 1–9.
PMCID: PMC1994043
A review of pulmonary arterial hypertension: role of ambrisentan
Robyn J Barst
Vasc Health Risk Manag. 2007 February; 3(1): 11–22.
PMCID: PMC1994051
Moexipril and left ventricular hypertrophy
George S Chrysant and PK Nguyen
Vasc Health Risk Manag. 2007 February; 3(1): 23–30.
PMCID: PMC1994034
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, and Christian Torp-Pedersen
Vasc Health Risk Manag. 2007 February; 3(1): 31–37.
PMCID: PMC1994038
What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of:“All that is necessary for the triumph of evil is that good men do nothing?”
Chris R Triggle and David J Triggle
Vasc Health Risk Manag. 2007 February; 3(1): 39–53.
PMCID: PMC1994041
Cardiometabolic aspects of polycystic ovarian syndrome
Li Wei Cho, Harpal S Randeva, and Stephen L Atkin
Vasc Health Risk Manag. 2007 February; 3(1): 55–63.
PMCID: PMC1994046
Foot ulcers in the diabetic patient, prevention and treatment
Stephanie C Wu, Vickie R Driver, James S Wrobel, and David G Armstrong
Vasc Health Risk Manag. 2007 February; 3(1): 65–76.
PMCID: PMC1994045
Trandolapril/verapamil combination in hypertensive diabetic patients
José A García Donaire and Luis M Ruilope
Vasc Health Risk Manag. 2007 February; 3(1): 77–82.
PMCID: PMC1994049
Inhaled human insulin (Exubera®): clinical profile and patient considerations
Anthony H Barnett and Sri Bellary
Vasc Health Risk Manag. 2007 February; 3(1): 83–91.
PMCID: PMC1994047
A review of picotamide in the reduction of cardiovascular events in diabetic patients
Andrea Celestini and Francesco Violi
Vasc Health Risk Manag. 2007 February; 3(1): 93–98.
PMCID: PMC1994050
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
Jutta Dierkes, Claus Luley, and Sabine Westphal
Vasc Health Risk Manag. 2007 February; 3(1): 99–108.
PMCID: PMC1994037
Management of atrial fibrillation
Puneet Kakar, Christopher J Boos, and Gregory YH Lip
Vasc Health Risk Manag. 2007 February; 3(1): 109–116.
PMCID: PMC1994040
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis
Peter J Little, Mandy L Ballinger, and Narin Osman
Vasc Health Risk Manag. 2007 February; 3(1): 117–124.
PMCID: PMC1994044
Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy
Christoph Schindler, Peter Bramlage, Wilhelm Kirch, and Carlos M Ferrario
Vasc Health Risk Manag. 2007 February; 3(1): 125–137.
PMCID: PMC1994039
Overweight, physical activity and high blood pressure in children: a review of the literature
Brian Torrance, K Ashlee McGuire, Richard Lewanczuk, and Jonathan McGavock
Vasc Health Risk Manag. 2007 February; 3(1): 139–149.
PMCID: PMC1994042
A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
Aaron B Waxman
Vasc Health Risk Manag. 2007 February; 3(1): 151–157.
PMCID: PMC1994033
Original Research
Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBI-TER 2
Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, and Karen A Grace
Vasc Health Risk Manag. 2007 February; 3(1): 159–164.
PMCID: PMC1994036
Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials
Ramzi EL Féghali, Sophie Nisse-Durgeat, and Roland Asmar
Vasc Health Risk Manag. 2007 February; 3(1): 165–171.
PMCID: PMC1994048
Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial
Jean-Jacques Mourad, Viet Nguyen, Marilucy Lopez-Sublet, and Bernard Waeber
Vasc Health Risk Manag. 2007 February; 3(1): 173–180.
PMCID: PMC1994035
Other Issues:  previous | next | latest | archive